Citigroup Inc Incannex Healthcare LTD Transaction History

Citigroup Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$3.86 - $9.14 $23 - $54	-6 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$9.16 - $35.5 $54 - $213	6 New	6 $0

Ticker IXHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 51,693,400
Market Cap $97.2M
Description
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.